"The new policy imposes a 100% tariff on branded products and pharmaceutical ingredients entering the U.S., while exempting generic medications and certain specialty drugs."
"Trump's administration has been pursuing tariffs across various sectors, using investigations to justify these financial measures based on national security concerns."
President Trump is implementing new tariffs on branded pharmaceuticals, imposing a 100% tariff on imported products and ingredients. Generic medications, which account for most U.S. prescriptions, are exempt, along with rare disease drugs, cancer therapies, fertility drugs, and medicines for chemical threats. The tariffs will take effect at the end of July for large firms and September for smaller ones. This policy is part of a broader strategy to encourage domestic production and follows a Section 232 investigation into the national security implications of pharmaceutical imports.
#pharmaceutical-tariffs #trump-administration #national-security #biopharmaceuticals #import-policies
Read at MedCity News
Unable to calculate read time
Collection
[
|
...
]